UCB Attempts To Protect Keppra Franchise
This article was originally published in The Pink Sheet Daily
Executive Summary
Company asks FDA to strengthen guidelines associated with generic versions of antiepileptic drugs, as Keppra patent expiration approaches.
You may also be interested in...
Generic Keppra Set For Launch In November 2008 After UCB Settles
Mylan could launch generic versions of the antiepileptic Nov. 1, 2008, two months ahead of anticipated exclusivity expiry of levetiracetam.
Generic Keppra Set For Launch In November 2008 After UCB Settles
Mylan could launch generic versions of the antiepileptic Nov. 1, 2008, two months ahead of anticipated exclusivity expiry of levetiracetam.
UCB Receives “Complete Response” Letter For Cimzia
Firm says FDA seeks new information and clarification regarding the BLA.